Treatment of recalcitrant psoriasis with daclizumab

被引：13

作者：

Wohlrab, J ^{[1
]}

Fischer, M ^{[1
]}

Taube, KM ^{[1
]}

Marsch, WC ^{[1
]}

机构：

[1] Univ Halle Wittenberg, Klin & Poliklin Dermatol & Venereol, D-06097 Halle, Germany

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2001年 / 144卷 / 01期

关键词：

D O I：

10.1046/j.1365-2133.2001.03991.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：209 / 210

页数：2

共 5 条

[1]

Barker Jonathan N. W. N., 1998, Journal of Dermatology (Tokyo), V25, P778

[2] The pathogenesis of psoriasis: Immunological facts and speculations [J].

Bos, JD ;

De Rie, MA .

IMMUNOLOGY TODAY, 1999, 20 (01) :40-46

[3] Guidelines for measurement of skin colour and erythema - A report from the standardization group of the European society of contact dermatitis [J].

Fullerton, A ;

Fischer, T ;

Lahti, A ;

Wilhelm, KP ;

Takiwaki, H ;

Serup, J .

CONTACT DERMATITIS, 1996, 35 (01) :1-10

[4] Reduction of acute renal allograft rejection by daclizumab [J].

Nashan, B ;

Light, S ;

Hardie, IR ;

Lin, A ;

Johnson, JR .

TRANSPLANTATION, 1999, 67 (01) :110-115

[5] Treatment of noninfectious intermediate and posterior uveitis with the humanized anti-Tac mAb: A phase I/II clinical trial [J].

Nussenblatt, RB ;

Fortin, E ;

Schiffman, R ;

Rizzo, L ;

Smith, J ;

Van Veldhisen, P ;

Sran, P ;

Yaffe, A ;

Goldman, CK ;

Waldmann, TA ;

Whitcup, SM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (13) :7462-7466

← 1 →